New Key Statistics Module, Z-Score and F-Score
OTCPK:SOLTF Key Ratios
| Market Cap $ M | 703.93 |
| Enterprise Value $ M | 834.80 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 26.93 |
| Price/Book | 1.65 |
| Price/Sales | 3.80 |
| Price/Free Cash Flow | 70.28 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 197.00 |
| EPS (TTM) $ | -0.27 |
| Beneish M-Score | -1.53 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -200.40 |
| EV-to-EBIT | -43.22 |
| EV-to-EBITDA | 112.29 |
| PEG | -- |
| Shares Outstanding M | 89.90 |
| Net Margin (%) | -12.68 |
| Operating Margin % | -14.96 |
| Pre-tax Margin (%) | -17.45 |
| Quick Ratio | 3.96 |
| Current Ratio | 4.11 |
| ROA % (ttm) | -2.58 |
| ROE % (ttm) | -5.76 |
| ROIC % (ttm) | -3.52 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.91 |
SOLTF Number of Guru Trades
SOLTF Volume of Guru Trades
Gurus Latest Trades with OTCPK:SOLTF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:SOLTF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Nxera Pharma Co Ltd Insider Transactions
No Available Data
News about OTCPK:SOLTF
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers